258 related articles for article (PubMed ID: 30617907)
1. Continuous subcutaneous apomorphine in advanced Parkinson's disease patients treated with deep brain stimulation.
Sesar Á; Fernández-Pajarín G; Ares B; Relova JL; Arán E; Rivas MT; Gelabert-González M; Castro A
J Neurol; 2019 Mar; 266(3):659-666. PubMed ID: 30617907
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients.
Sesar Á; Fernández-Pajarín G; Ares B; Rivas MT; Castro A
J Neurol; 2017 May; 264(5):946-954. PubMed ID: 28364292
[TBL] [Abstract][Full Text] [Related]
3. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous apomorphine infusion in Parkinson's disease: causes of discontinuation and subsequent treatment strategies.
Olivola E; Fasano A; Varanese S; Lena F; Santilli M; Femiano C; Centonze D; Modugno N
Neurol Sci; 2019 Sep; 40(9):1917-1923. PubMed ID: 31111272
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous apomorphine monotherapy in Parkinson's disease.
Papuć E; Trzciniecka O; Rejdak K
Ann Agric Environ Med; 2019 Mar; 26(1):133-137. PubMed ID: 30922043
[TBL] [Abstract][Full Text] [Related]
6. Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation.
Elia AE; Dollenz C; Soliveri P; Albanese A
Eur J Neurol; 2012 Jan; 19(1):76-83. PubMed ID: 21645174
[TBL] [Abstract][Full Text] [Related]
7. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
Alegret M; Valldeoriola F; Martí M; Pilleri M; Junqué C; Rumià J; Tolosa E
Mov Disord; 2004 Dec; 19(12):1463-9. PubMed ID: 15390065
[TBL] [Abstract][Full Text] [Related]
8. Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.
Drapier S; Gillioz AS; Leray E; Péron J; Rouaud T; Marchand A; Vérin M
Parkinsonism Relat Disord; 2012 Jan; 18(1):40-4. PubMed ID: 21890396
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study.
Katzenschlager R; Poewe W; Rascol O; Trenkwalder C; Deuschl G; Chaudhuri KR; Henriksen T; van Laar T; Lockhart D; Staines H; Lees A
Parkinsonism Relat Disord; 2021 Feb; 83():79-85. PubMed ID: 33486139
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson's Disease: The APO-NIGHT Study.
Fernández-Pajarín G; Sesar Á; Ares B; Castro A
J Parkinsons Dis; 2016 Oct; 6(4):787-792. PubMed ID: 27662329
[TBL] [Abstract][Full Text] [Related]
11. A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation.
Antonini A; Isaias IU; Rodolfi G; Landi A; Natuzzi F; Siri C; Pezzoli G
J Neurol; 2011 Apr; 258(4):579-85. PubMed ID: 20972684
[TBL] [Abstract][Full Text] [Related]
12. Deep brain stimulation of the subthalamic nucleus: effectiveness in advanced Parkinson's disease patients previously reliant on apomorphine.
Varma TR; Fox SH; Eldridge PR; Littlechild P; Byrne P; Forster A; Marshall A; Cameron H; McIver K; Fletcher N; Steiger M
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):170-4. PubMed ID: 12531942
[TBL] [Abstract][Full Text] [Related]
13. The role of subcutaneous infusion of apomorphine in Parkinson's disease.
Wenzel K; Homann CN; Fabbrini G; Colosimo C
Expert Rev Neurother; 2014 Jul; 14(7):833-43. PubMed ID: 24917215
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study.
Borgemeester RWK; van Laar T
Parkinsonism Relat Disord; 2017 Dec; 45():33-38. PubMed ID: 29032012
[TBL] [Abstract][Full Text] [Related]
15. [Apomorphine in advanced Parkinson disease].
Bogucki A
Neurol Neurochir Pol; 2013; 47(5):476-83. PubMed ID: 24166569
[TBL] [Abstract][Full Text] [Related]
16. Continuous perioperative apomorphine in deep brain stimulation surgery for Parkinson's disease.
Slotty PJ; Wille C; Kinfe TM; Vesper J
Br J Neurosurg; 2014 Jun; 28(3):378-82. PubMed ID: 24073755
[TBL] [Abstract][Full Text] [Related]
17. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.
Richter D; Bartig D; Jost W; Jörges C; Stumpe B; Gold R; Krogias C; Tönges L
J Neural Transm (Vienna); 2019 Jul; 126(7):879-888. PubMed ID: 31222604
[TBL] [Abstract][Full Text] [Related]
19. Continuous Subcutaneous Apomorphine Infusion before Subthalamic Deep Brain Stimulation: A Prospective, Comparative Study in 20 Patients.
Fernández-Pajarín G; Sesar Á; Ares B; Jiménez-Martín I; Gelabert M; Arán-Echabe E; Relova JL; Castro A
Mov Disord Clin Pract; 2021 Nov; 8(8):1216-1224. PubMed ID: 34761055
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
